Paper
23 February 2009 Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment
A. A. Petryk, A. J. Giustini, P. Ryan, R. R. Strawbridge, P. J. Hoopes
Author Affiliations +
Abstract
The benefit of combining hyperthermia and chemotherapy to treat cancer is well established. However, combined therapy has not yet achieved standard of care status. The reasons are numerous and varied, however the lack of significantly greater tumor cell sensitivity to heat (as compared to normal cells) and the inability to deliver heat to the tumor in a precise manner have been major factors. Iron oxide nanoparticle (IONP) hyperthermia, alone and combined with other modalities, offers a new direction in hyperthermia cancer therapy via improved tumor targeting and an improved therapeutic ratio. Our preliminary studies have demonstrated tumor cell cytotoxicity (in vitro and in vivo) with IONP heat and cisplatinum (CDDP) doses lower than those necessary when using conventional heating techniques or cisplatinum alone. Ongoing studies suggest such treatment could be further improved through the use of targeted nanoparticles.
© (2009) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
A. A. Petryk, A. J. Giustini, P. Ryan, R. R. Strawbridge, and P. J. Hoopes "Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment", Proc. SPIE 7181, Energy-based Treatment of Tissue and Assessment V, 71810N (23 February 2009); https://doi.org/10.1117/12.810024
Lens.org Logo
CITATIONS
Cited by 6 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Nanoparticles

Iron

Oxides

Cancer

In vivo imaging

In vitro testing

Back to Top